COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]
COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]
Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]
Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
CRETA |
|
| ActiveMT | IDR 307.100.000 |
| Trend MT | IDR 339.250.000 |
| Trend IVT | IDR 359.950.000 |
| Style IVT | IDR 404.750.000 |
| Prime IVT | IDR 435.350.000 |
| N line | IDR 468.400.000 |
| N line Turbo | IDR 515.300.000 |
IONIQ 5 |
|
| Prime Standard Range | IDR 817.000.000 |
| Prime Long Range | IDR 859.500.000 |
| Signature Standard Range | IDR 881.900.000 |
| Signature long Range | IDR 933.700.000 |
| N·Line | IDR 1.507.900.0000 |
IONIQ 6 |
|
| Signature | IDR 1.241.000.000 |
KONA Electric |
|
| Style Standard Range | IDR 573.350.000 |
| Prime Standard Range | IDR 591.500.000 |
| Prime Long Range | IDR 642.550.000 |
| Signature Standard Range | IDR 659.650.000 |
| Signature Long Range | IDR 676.600.000 |
| N-Line | IDR 697.550.000 |
New CRETA |
|
| Active | IDR Rp. 299.700.000 |
| Trend | IDR Rp. 331.640.000 |
| Style | IDR |
| Prime | IDR |
| N Line | IDR |
New TUCSON |
|
| Gasoline 2.0 MPl | IDR 660.300.000 |
| Hybrid 1.6 T-HEV | IDR 775.300.000 |
PALISADE |
|
| Prime | IDR 954.300,000 |
| Signature | IDR 1.100.200.000 |
| XRT Signature | IDR 1.129.100.000 |
| XRT Signature AWD | IDR 1.271.000.000 |
| Signature (Hybrid) | IDR 1.112.000.000 |
| Calligraphy (Hybrid) | IDR 1.281.000.000 |
| Calligraphy AWD (Hybrid) | IDR 1.366.000.000 |
STARGAZER |
|
| Active MT | IDR 264.400.000 |
| Active IVT | IDR 277.650.000 |
| Essential MT | IDR 276.400.000 |
| Essential IVT | IDR 288.200.000 |
| Essential Tech IVT | IDR 309.200.000 |
| Prime IVT | IDR 338.000.000 |
STARGAZER Cartenz |
|
| TREND | IDR 269.900.000 |
STARGAZER Cartenz X |
|
| Trend | IDR Rp. 361.900.000 |
| Style | IDR Rp. 374.900.000 |
| Prime Package | IDR Rp. 391.900.000 |
STARGAZER X |
|
| Style | IDR 354.050.000 |
| Prime | IDR 364.800.000 |
STARIA |
|
| 7S Signature | IDR 1.084.400.000 |
| 9S Signature | IDR 946.700.000 |
The all-new PALISADE |
|
| Signature | IDR Rp. 1.274.000.000 |
| Calligraphy | IDR |
| Calligraphy AWD | IDR |
The All-New SANTA FE |
|
| Prime | IDR 732.600.000 |
| Calligraphy | IDR 821.200.000 |
| Prime Hybrid | IDR 823.000.000 |
| Calligraphy Hybrid | IDR 909.400.000 |
VENUE |
|
| 1.0 Turbo | IDR Rp. 340.000.000 |